Cite
APA Citation
Vickers, R. J., Tillotson, G. S., Nathan, R., Hazan, S., Pullman, J., Lucasti, C., Deck, K., Yacyshyn, B., Maliakkal, B., Pesant, Y., Tejura, B., Roblin, D., Gerding, D. N., Wilcox, M. H., & , (n.d.). efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study. Lancet infectious diseases, 17(7), 735–744. http://access.bl.uk/ark:/81055/vdc_100047035316.0x00002b